Image

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

Imaging Study for Sarcoma and Gastrointestinal Cancer

Recruiting
15 years and older
All
Phase 1/2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates sarcoma and gastrointestinal tract cancer. It seeks to understand the use of 64Cu-LNTH-1363S in imaging these conditions.

The study evaluates the safety and effectiveness of the investigational imaging substance, focusing on its distribution in the body and its potential to show FAP expression in tumors.

  • Who can participate: Participants must be 15 years or older with a confirmed diagnosis of sarcoma or gastrointestinal tract cancer. Adequate kidney function and agreement to provide tissue samples are required.
  • Study details: Participants will receive an investigational imaging substance. An inactive substance may be used for comparison.
  • Study timelines and visits: The study will last approximately 3 weeks for Part 1 and 10 to 11 weeks for Part 2. The study requires 1 visit for Part 1 and 1 visit for Part 2.
Print
Study details
    Metastatic Sarcoma
    Esophageal Cancer
    Gastric Cancer
    Pancreatic Cancer
    Colorectal Cancer
    Sarcoma

NCT06298916

Lantheus Medical Imaging

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.